Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin’s lymphoma

BACKGROUND: The regimen of cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP) is an efficient treatment of non-Hodgkin’s lymphoma (NHL). This study aimed to assess the efficacy and toxicity of dose-adjusted CHOP alone or in combination with rituximab (R-CHOP) by examining the stem c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Chin J Cancer
Autors principals: Shi, Yuankai, Zhou, Ping, Han, Xiaohong, He, Xiaohui, Zhou, Shengyu, Liu, Peng, Yang, Jianliang, Zhang, Changgong, Gui, Lin, Qin, Yan, Yang, Sheng, Zhao, Liya, Yao, Jiarui, Zhang, Shuxiang
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2015
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4593367/
https://ncbi.nlm.nih.gov/pubmed/26370464
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40880-015-0045-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars